PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution

Akbarieh, 1992, Liposomal system for the targeting and controlled release of praziquantel, Drug Dev. Ind. Pharm., 18, 303, 10.3109/03639049209043701

Allemann, 1998, Polymeric nano- and microparticles for the oral delivery of peptides and peptidomimetics, Adv. Drug Del. Rev., 34, 171, 10.1016/S0169-409X(98)00039-8

Anderson, 1997, Biodegradation and biocompatibility of PLA and PLGA microspheres, Adv. Drug Del. Rev., 28, 5, 10.1016/S0169-409X(97)00048-3

Becket, 1999, Improvement of the in vitro dissolution of praziquantel by complexation with α-,β- and γ-ciclodextrins, Int. J. Pharm., 179, 65, 10.1016/S0378-5173(98)00382-2

Brannon-Peppas, 1995, Recent advances on the use of biodegradable microparticles and nanoparticles in controlled drug delivery, Int. J. Pharm., 116, 1, 10.1016/0378-5173(94)00324-X

Burkersroda, 2002, Why degradable polymers undergo surface erosion or bulk erosion, Biomaterials, 23, 221, 10.1016/S0142-9612(02)00170-9

Chorny, 2002, Lipophilic drug loaded nanospheres prepared by nanoprecipitation: effect of formulating variables on size, drug recovery and release kinetics, J. Contr. Release, 83, 389, 10.1016/S0168-3659(02)00211-0

El-Arini, 1998, Dissolution properties of praziquantel-PVP systems, Pharm. Acta Helv., 73, 89, 10.1016/S0031-6865(97)00051-4

Feng, 2001, Effects of emulsifiers on the controlled release of paclitaxel (Taxol®) from nanospheres of biodegradable polymers, J. Contr. Release, 71, 53, 10.1016/S0168-3659(00)00364-3

Görner, 1999, Lidocaine-loaded biodegradable nanospheres. I. Optimization of the drug incorporation into the polymer matrix, J. Contr. Release, 57, 59, 10.1016/S0168-3659(98)00121-7

Hans, 2002, Biodegradable nanoparticles for drug delivery and targeting, Curr. Opin. Sol. State Mater. Sci., 6, 319, 10.1016/S1359-0286(02)00117-1

Jain, 2000, The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glicolide) (PLGA) devices, Biomaterials, 21, 2475, 10.1016/S0142-9612(00)00115-0

Jeon, 2000, Effect of solvent on the preparation of surfactant-free poly(d,l-lactide-co-glycolide) nanoparticles and norfloxacin release characteristics, Int. J. Pharm., 207, 99, 10.1016/S0378-5173(00)00537-8

Jung, 2000, Sulfobutyllated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) facilitates the preparation of small negatively charged biodegradable nanospheres, J. Contr. Release, 67, 157, 10.1016/S0168-3659(00)00201-7

Kwon, 2001, Preparation of PLGA nanoparticles containing estrogen by emulsification-diffusion method, Colloid Surf. A, 182, 123, 10.1016/S0927-7757(00)00825-6

Lamprecht, 2001, Design of rolipram-loaded nanoparticles: comparison of two preparation methods, J. Contr. Release, 71, 297, 10.1016/S0168-3659(01)00230-9

Meier, 2001, Investigation of praziquantel metabolism in isolated rat hepatocytes, J. Pharm. Biomater. Anal., 26, 409, 10.1016/S0731-7085(01)00417-4

Murakami, 1999, Preparation of poly(dl-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method, Int. J. Pharm., 187, 143, 10.1016/S0378-5173(99)00187-8

Nishioka, 2001, Lymphatic targeting with nanoparticulate system, Adv. Drug Del. Rev., 47, 55, 10.1016/S0169-409X(00)00121-6

Panyam, 2003, Biodegradable nanoparticles for drug and gene delivery to cells and tissue, Adv. Drug Del. Rev., 55, 329, 10.1016/S0169-409X(02)00228-4

Park, 1995, Degradation of poly(lactide-co-glicolide acid) microspheres: effect of copolymer composition, Biomaterials, 16, 1123, 10.1016/0142-9612(95)93575-X

Quintanar-Guerrero, 1996, Influence of stabilizing agents and preparatives variables on the formation of poly(d,l-lactic acid) nanoparticles by an emulsification-diffusion technique, Int. J. Pharm., 143, 133, 10.1016/S0378-5173(96)04697-2

Sahoo, 2002, Residual polyvinyl alcohol associated with poly(d,l-lactide-co-glicolide) nanoparticles affects their physical properties and cellular uptake, J. Contr. Release, 82, 105, 10.1016/S0168-3659(02)00127-X

Soppimath, 2001, Biodegradable polymeric nanoparticles as drug delivery devices, J. Contr. Release, 70, 1, 10.1016/S0168-3659(00)00339-4

Uhrich, 1999, Polymeric systems for controlled drug release, Chem. Rev., 99, 3181, 10.1021/cr940351u

Vert, 1998, Something new in the field of PLA/GA bioresorbable polymers?, J. Contr. Release, 53, 85, 10.1016/S0168-3659(97)00240-X

Xiao, 1985, Effect of praziquantel on different developmental stages of Schistosoma mansoni in vitro and in vivo, J. Infect. Dis., 151, 1130, 10.1093/infdis/151.6.1130